Liminatus Pharma: 10.9% Holder Discloses 5.5M Shares

Liminatus Pharma, Inc. received a Schedule 13G/A disclosure showing that Ewon Comfortech Co., Ltd. beneficially owns 5,500,000 shares of Common Stock, representing 10.9% of the class based on 55,971,633 shares outstanding as of July 1, 2026.

Rhea-AI Filing Summary

Liminatus Pharma, Inc. received a Schedule 13G/A disclosure showing that Ewon Comfortech Co., Ltd. beneficially owns 5,500,000 shares of Common Stock, representing 10.9% of the class based on 55,971,633 shares outstanding as of July 1, 2026. The filing reports sole voting power of 1,126,397 shares and sole dispositive power over 5,500,000 shares. The amendment is signed by Joo Sung Park, CEO on 07/06/2026.

Insights

Equity Securities Analyst

13G/A shows a substantial passive stake: 5.5M shares (10.9%).

The filing lists 5,500,000 shares beneficially owned and calculates 10.9% based on 55,971,633 shares outstanding as of July 1, 2026. The holder reports sole dispositive power over the full stake and more limited sole voting power.

Because this is a Schedule 13G/A amendment, it signals a disclosed, passive beneficial ownership position; subsequent disclosures would show any active changes. Future filings may show voting or disposition changes if they occur.

Key Figures

Beneficial ownership: 5,500,000 shares Percent of class: 10.9% Sole voting power: 1,126,397 shares +2 more

5 metrics

Beneficial ownership 5,500,000 shares Amount beneficially owned reported in Schedule 13G/A

Percent of class 10.9% Calculated based on 55,971,633 shares outstanding as of July 1, 2026

Sole voting power 1,126,397 shares Number with sole power to vote as reported in Item 4(c)(i)

Sole dispositive power 5,500,000 shares Number with sole power to dispose as reported in Item 4(c)(iii)

Shares outstanding 55,971,633 shares Used to calculate the 10.9% figure as of July 1, 2026

Key Terms

Schedule 13G/A, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned regulatory

"Amount beneficially owned: 5,500,000 (b) Percent of class: 10.9 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 5,500,000"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who filed the Schedule 13G/A for Liminatus Pharma (LIMN)?

Ewon Comfortech Co., Ltd. filed the Schedule 13G/A, reporting beneficial ownership of 5,500,000 shares. The filing is signed by Joo Sung Park, Chief Executive Officer on 07/06/2026.

How many Liminatus shares does Ewon Comfortech beneficially own?

5,500,000 shares of Common Stock are reported as beneficially owned by Ewon Comfortech. The filing states this equals 10.9% of the class based on 55,971,633 shares outstanding as of July 1, 2026.

What voting and dispositive powers does the filer report?

The filer reports sole voting power for 1,126,397 shares and sole dispositive power for 5,500,000 shares. The filing shows no shared voting or dispositive power for the reported holdings.

What outstanding share count does the filing use to calculate the percentage?

The percentage is calculated using 55,971,633 shares outstanding as of July 1, 2026, as stated in the filing's percentage comment for the Schedule 13G/A.

Does the Schedule 13G/A indicate changes in control or active intent?

The filing reports beneficial ownership and power details but does not state control changes or active intent. It is an amendment disclosing a 10.9% passive stake; no active-control language is included in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:56 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Liminatus Pharma, Inc.

(Name of Issuer)

Common Stock , par value $0.0001 per share

(Title of Class of Securities)

53271X108

(CUSIP Number)

06/24/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 53271X108

1

Names of Reporting Persons

Ewon Comfortech Co., Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

KOREA, REPUBLIC OF

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,126,397.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,500,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.9 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: * Percentage is calculated based on 55,971,633 shares of Common Stock outstanding on July 1, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Liminatus Pharma, Inc.
(b)	Address of issuer's principal executive offices: 2251 Stern Goodman Street, Suite E, Fullerton, CA 92833
Item 2.
(a)	Name of person filing: Ewon Comfortech Co., Ltd.
(b)	Address or principal business office or, if none, residence: 8 Cheomdan 1-ro Jeongeup, Jeonbuk, 56212 Republic of South Korea
(c)	Citizenship: Republic of South Korea
(d)	Title of class of securities: Common Stock , par value $0.0001 per share
(e)	CUSIP No.: 53271X108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5,500,000
(b)	Percent of class: 10.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,126,397
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5,500,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ewon Comfortech Co., Ltd.

Signature:	/s/ Joo Sung Park
Name/Title:	Joo Sung Park, Chief Executive Officer
Date:	07/06/2026